Zydus gets FDA green light for drugs to treat diabetes, shingles
Zydus Lifesciences, a subsidiary of Zydus Pharmaceuticals US, has received two tentative FDA approvals, one for treating type 2 diabetes and the other.
Drugs
Pharma